To ask Her Majesty’s Government how they plan to ensure that, in the implementation of the NHS Supply Chain generic project plans for a national formulary for wound care, innovative small companies are not at a disadvantage in bidding for contracts.
Answered on
4 January 2016
Innovation is welcomed as part of this process and the clinical specifications may support smaller companies who demonstrate their capability to meet the requirements. One advantage of the NHS Supply Chain venture for smaller companies is that it can act as a single point of entry into the National Health Service and lower the ‘cost of sales’.
Answered by
Department of Health and Social Care